BlackRock Inc. Buys Shares of 123,223,409 CVS Health Corporation $CVS

BlackRock Inc. bought a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 123,223,409 shares of the pharmacy operator's stock, valued at approximately $12,747,462,000. BlackRock Inc. owned approximately 9.66% of CVS Health as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in the stock. Caitong International Asset Management Co. Ltd increased its stake in CVS Health by 407.2% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator's stock valued at $26,000 after purchasing an additional 281 shares in the last quarter. Swiss RE Ltd. acquired a new stake in CVS Health in the fourth quarter valued at $26,000. Sankala Group LLC purchased a new position in shares of CVS Health in the fourth quarter valued at $28,000. Global Trust Asset Management LLC increased its position in shares of CVS Health by 344.8% in the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator's stock valued at $28,000 after buying an additional 300 shares in the last quarter. Finally, Mcguire Capital Advisors Inc. acquired a new position in shares of CVS Health during the 4th quarter worth $28,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

Insider Buying and Selling at CVS Health

In related news, Director Larry Robbins sold 1,018,000 shares of the company's stock in a transaction that occurred on Wednesday, May 20th. The shares were sold at an average price of $93.82, for a total transaction of $95,508,760.00. Following the completion of the transaction, the director owned 5,195,261 shares of the company's stock, valued at approximately $487,419,387.02. This represents a 16.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.85% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of research reports. HSBC reissued a "hold" rating and issued a $103.00 price objective on shares of CVS Health in a research note on Monday, July 6th. Barclays lifted their target price on shares of CVS Health from $106.00 to $108.00 and gave the stock an "overweight" rating in a research report on Thursday, August 6th. Royal Bank Of Canada increased their price target on shares of CVS Health from $107.00 to $113.00 and gave the company an "outperform" rating in a research report on Thursday, July 9th. Weiss Ratings raised shares of CVS Health from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, August 5th. Finally, Mizuho lifted their price objective on CVS Health from $110.00 to $115.00 and gave the stock an "outperform" rating in a research report on Monday, June 8th. Twenty-two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat, CVS Health currently has a consensus rating of "Moderate Buy" and an average target price of $106.75.

CVS Health Trading Down 3.3%

Shares of CVS opened at $93.99 on Tuesday. CVS Health Corporation has a fifty-two week low of $69.40 and a fifty-two week high of $110.68. The company has a market capitalization of $120.21 billion, a PE ratio of 24.87, a price-to-earnings-growth ratio of 0.93 and a beta of 0.61. The stock has a fifty day moving average of $102.46 and a two-hundred day moving average of $88.41. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business had revenue of $106.10 billion for the quarter, compared to analysts' expectations of $100.03 billion. During the same quarter last year, the firm earned $1.81 earnings per share. The business's revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, analysts forecast that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. CVS Health's dividend payout ratio is currently 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source